Disopyramide Phosphate Powder
NDC Package 51014-7863-0
Package Information
Disopyramide Phosphate powders is a medication used to treat certain types of serious (possibly fatal) irregular heartbeat, such as persistent ventricular tachycardia. This formulation utilizes a powder delivery system. Marketed by Pcas Finland, this product is identified by NDC 51014-7863.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51014 - Pcas Finland
- 51014-7863 -
- 51014-7863-0 - 45 kg in 1 DRUM
- 51014-7863 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51014-7863-0 identifies a specific commercial package of 45 kg in 1 drum of Disopyramide Phosphate (UNFINISHED drug), a bulk ingredient labeled by Pcas Finland. This powder is formulated for use and contains disopyramide phosphate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pcas Finland on April 26, 2010. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat certain types of serious (possibly fatal) irregular heartbeat, such as persistent ventricular tachycardia. It is used to restore normal heart rhythm and maintain a regular, steady heartbeat. Disopyramide is known as an anti-arrhythmic drug. It works by blocking certain electrical signals in the heart that can cause an irregular heartbeat. Treating an irregular heartbeat can decrease the risk for blood clots, and this effect can reduce your risk of heart attack or stroke.
How is this Pcas Finland product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51014786300. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.